Pharma Journalist -

AbbVie and Calibr announced a collaboration to develop T-cell therapies aimed primarily at cancer, including solid tumors. This collaboration broadens AbbVie's oncology research to…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) and granted Priority Review for baloxavir marboxil as a single-dose, oral…
Read More...

Aquinox Pharmaceuticals announced that the Phase 3 LEADERSHIP 301 clinical trial evaluating once-daily, oral rosiptor (AQX-1125) for the treatment of interstitial cystitis/bladder pain…
Read More...

CIMS Medica presents the 7th edition of Indian Pharma Expo (IPE) 2018, to be held on 7th, 8th & 9th August 2018 at Hall No. 12-A, Pragati Maidan, New Delhi. Previous year IPE set…
Read More...

The center will be based around LUMICKS' C-Trap optical tweezers-fluorescence microscope, which for the first time enables real-time observation and probing of biomolecular…
Read More...

In the quest to develop a drug to effectively treat aggressive prostate cancer, NucleoBio Inc. has demonstrated efficacy for its newest product, Prostreat. Prostreat outperforms…
Read More...

Starpharma and Mundipharma today announced they have signed a licence agreement for the sales and marketing rights to VivaGel BV for 43 countries in Europe, Russia, the Commonwealth of…
Read More...

AbbVie and Calico announced an extension of their collaboration to discover, develop and bring to market new therapies for patients with age-related diseases, including…
Read More...

IsoPlexis Corporation (IsoPlexis), a privately held life sciences company at the forefront of single-cell analytics technology, announced its collaboration with Nektar Therapeutics. The…
Read More...

Erimos Pharmaceuticals announced in collaboration with Adult Brain Tumor Consortium (ABTC) and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, initiation of a multi-center…
Read More...